CONDORELLI, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 13.341
AS - Asia 7.516
EU - Europa 2.367
SA - Sud America 1.437
AF - Africa 361
Continente sconosciuto - Info sul continente non disponibili 248
OC - Oceania 9
Totale 25.279
Nazione #
US - Stati Uniti d'America 13.080
SG - Singapore 4.661
CN - Cina 1.258
BR - Brasile 1.209
VN - Vietnam 707
IT - Italia 444
FI - Finlandia 429
IE - Irlanda 346
DE - Germania 245
NG - Nigeria 242
HK - Hong Kong 227
FR - Francia 178
GB - Regno Unito 160
IN - India 148
CA - Canada 124
NL - Olanda 113
SE - Svezia 112
AR - Argentina 91
BD - Bangladesh 82
RU - Federazione Russa 76
MX - Messico 71
IQ - Iraq 64
TR - Turchia 49
JP - Giappone 48
BE - Belgio 40
ID - Indonesia 36
EC - Ecuador 32
ES - Italia 30
PL - Polonia 30
ZA - Sudafrica 29
IL - Israele 28
CZ - Repubblica Ceca 27
UA - Ucraina 27
PK - Pakistan 25
CO - Colombia 24
VE - Venezuela 23
CL - Cile 22
MA - Marocco 22
SA - Arabia Saudita 20
JM - Giamaica 16
PH - Filippine 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 14
EG - Egitto 14
JO - Giordania 14
KE - Kenya 13
MY - Malesia 13
PY - Paraguay 13
AZ - Azerbaigian 12
DZ - Algeria 12
KR - Corea 12
RO - Romania 12
AT - Austria 10
GR - Grecia 10
UY - Uruguay 10
CR - Costa Rica 9
PT - Portogallo 9
BB - Barbados 8
ET - Etiopia 8
HN - Honduras 8
PE - Perù 8
BG - Bulgaria 7
LT - Lituania 7
TH - Thailandia 7
AU - Australia 6
GE - Georgia 6
BY - Bielorussia 5
CH - Svizzera 5
EE - Estonia 5
HR - Croazia 5
MD - Moldavia 5
NO - Norvegia 5
NP - Nepal 5
OM - Oman 5
PR - Porto Rico 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
IR - Iran 4
KG - Kirghizistan 4
RS - Serbia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
CG - Congo 3
CU - Cuba 3
DK - Danimarca 3
HU - Ungheria 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LY - Libia 3
MN - Mongolia 3
SK - Slovacchia (Repubblica Slovacca) 3
GA - Gabon 2
KH - Cambogia 2
Totale 25.002
Città #
Singapore 2.066
Chandler 1.717
Wilmington 1.497
Ashburn 831
The Dalles 762
San Jose 640
Shanghai 570
San Mateo 553
Ann Arbor 473
Council Bluffs 442
Helsinki 427
New York 427
Dallas 406
Boardman 373
Dublin 343
Leawood 248
Princeton 248
Lawrence 242
Benin City 241
Beijing 228
Ho Chi Minh City 228
Hong Kong 217
Hanoi 180
Los Angeles 174
Santa Clara 174
Milan 172
Woodbridge 136
Fairfield 127
Paris 124
São Paulo 103
Amsterdam 90
Columbus 81
Buffalo 74
Seattle 72
London 65
Pune 62
Toronto 52
San Diego 51
Rome 46
Chicago 41
Phoenix 41
Rio de Janeiro 41
Brussels 39
Falkenstein 39
Tokyo 35
Orem 32
Da Nang 31
Moscow 30
Haiphong 29
Naples 29
Norwalk 29
Baghdad 27
Mexico City 27
Munich 27
Warsaw 26
Falls Church 25
Montreal 25
Brasília 24
Chennai 23
Brooklyn 22
Curitiba 22
Abbiategrasso 21
Belo Horizonte 21
Houston 21
Boston 20
Charlotte 20
Stockholm 19
Johannesburg 18
Brno 17
Campinas 17
Atlanta 16
Dhaka 16
San Francisco 16
Tashkent 16
Figino 15
Denver 14
Frankfurt am Main 14
Guayaquil 14
Miami 14
Porto Alegre 14
Jakarta 13
Kocaeli 13
Ribeirão Preto 13
Baku 12
Changsha 12
Fortaleza 12
Hangzhou 12
Hải Dương 12
Kingston 12
Nairobi 12
Philadelphia 12
Hillsboro 11
Newark 11
Quito 11
Amman 10
Bogotá 10
Des Moines 10
Manchester 10
Salvador 10
St Louis 10
Totale 16.177
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 148
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 140
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 134
A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. 132
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 131
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 124
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 121
RNA (Epi)genetics in cardiovascular diseases 121
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population 119
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 117
[Continuity of care in heart failure: pilot study of the Tuscany region]. 114
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 113
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 113
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 112
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy 111
MicroRNAs and cardiac pathology 110
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 110
T cell costimulation blockade blunts pressure overload-induced heart failure 110
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 110
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes 109
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 109
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases 108
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure 106
Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease 105
Adenovirus-mediated gene transfer of the retinoblastoma family member p130/RB2 blocks restenosis after endothelial injury 104
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 104
T Cell Costimulation Blockade Blunts Age-Related Heart Failure 103
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 103
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling 102
The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 101
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 101
Epigenetics : a new mechanism of regulation of heart failure? 100
Therapeutic use of microRNAs in myocardial diseases 100
Translating cardioprotection for patient benefit : position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology 100
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy 100
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy 100
mTOR regulates brain morphogenesis by mediating GSK3 signaling. 99
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 99
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability 99
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. 99
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations 98
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 96
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair 96
Dietary essential amino acids for the treatment of heart failure with reduced ejection fraction 95
Single-Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation 95
Differential expression and functional role of GATA-2, NF-E2 and GATA-1 in normal adult erythropoiesis 94
Dr. John Ross Jr. 94
Association of FOXO3A locus with extreme longevity in the Southern Italian Centenarian Study 94
Opposing roles of Akt and STAT3 in protection of the maternal heart from peripartum stress 94
The possible role of chromosome X variability in hypertensive familiarity. 94
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 93
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 phospholamban 93
Activation of cAMP-PKA signalling in vivo inhibits smooth muscle cell proliferation after vascular injury 93
Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis. 92
Physiological myocardial hypertrophy: how and why? 92
MicroRNAs in cardiovascular biology and heart disease 92
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 91
Antiphosphotyrosine recovery of an isulin-stimulated receptor phosphatase activity in FRTL5 cells 91
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease 91
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice 91
Inhalation Therapy Delivers Nanoparticle-Based Therapeutic Biomolecules To The Diseased Heart 91
Abnormal responses to saline load in hypertensive patients with parental history of cardiovascular accidents 91
Mutated p21/WAF/CIP transgene overstatement reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice 90
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part I: Synthesis, characterization,and myoblast proliferation and differentiation 90
The long noncoding RNA landscape in cardiovascular disease: a brief update. 89
An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes 89
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts 89
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17 89
Reply to letter to the editor by Bonaventura et al 89
Circulating microRNAs and aerobic fitness : the HUNT-study 88
RBP and microRNA control of endothelial cell function 88
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis 88
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 88
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts 87
p300/CBP modulates co-operation between MEF2A and TR/RxR 87
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy 87
Uses and compositions comprising mirnas 87
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 86
The emerging role of microRNAs in cardiovascular biology 86
A Nitric Oxide-releasing Derivative of Enalapril, NCX-899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopathic Hamsters with Heart Failure 86
MicroRNAs in cardiovascular disease: an introduction for clinicians 86
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 86
Inhibition of Class I Histone Deacetylase with an Apicidine Derivative Prevents Cardiac Hypertrophy and Failure 85
MicroRNAs as Companion Biomarkers for the Diagnosis and Prognosis of Acute Coronary Syndromes 85
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism 85
The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle 84
Arterial remodeling and atherosclerosis: miRNAs involvement 84
Epigenetics in heart failure 84
Akt1 gene transfer to the endothelium corrects impaired endothelial dependent vasorelaxation in hypertensive rats 84
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway 83
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 83
Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction 83
p130/pRb2 has a similar yet distinctive growth suppressive properties as retinoblastoma family members, pRb and p107 82
Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis 82
MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium. 82
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 82
Long Noncoding RNA : a New Player of Heart Failure? 82
Chemerin processing in the myocardium: A mechanism in search of a function 81
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation 81
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia 81
Totale 9.740
Categoria #
all - tutte 164.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.178 0 20 20 316 20 18 42 201 103 91 246 101
2022/20234.490 546 116 347 553 500 398 4 419 840 395 300 72
2023/20242.523 213 246 551 147 78 358 141 149 41 63 174 362
2024/20254.234 140 89 71 96 188 482 299 504 526 924 489 426
2025/20268.912 1.386 494 386 681 306 414 2.755 487 502 557 437 507
2026/20271.252 470 782 0 0 0 0 0 0 0 0 0 0
Totale 25.279